tetano
Editor, Senior Moderator
Case Rep Obstet Gynecol
. 2022 Jan 7;2022:4186846.
doi: 10.1155/2022/4186846. eCollection 2022.
An Unusual Presentation of COVID-19 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A) in a Pregnant Woman
Mohamed Rishard[SUP] 1 2 [/SUP], Suren Perera[SUP] 2 [/SUP], Kushan Jayasinghe[SUP] 2 [/SUP], Amila Rubasinghe[SUP] 2 [/SUP], Sanjaya Athapaththu[SUP] 2 [/SUP], Malindu Edirisinghe[SUP] 2 [/SUP], Prabhodana Ranaweera[SUP] 1 2 [/SUP], Tushani Ranawaka[SUP] 1 [/SUP], Athula Kaluarachchi[SUP] 1 2 [/SUP], Priyankara Jayawardana[SUP] 2 [/SUP], Zacky Haniffa[SUP] 2 [/SUP]
Affiliations
Abstract
Based on available literature, pregnant women are at an increased risk of severe illness from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, compared to nonpregnant women. Consequences of coronavirus disease 2019 (COVID-19) in pregnancy have many implications in women's lives other than unfavorable obstetric outcomes. In addition to managing acute respiratory illness and symptoms, caregivers should be equipped to detect and manage the short-term, intermediate, and long-term consequences of SARS-CoV-2 infection as well. Many pregnant women can remain asymptomatic and continue their pregnancy without being diagnosed. Pregnancy outcomes and consequences of SARS-CoV-2 infected yet asymptomatic mothers have not been very well explained. Reports of a new multisystem inflammatory syndrome in children (MIS-C) and multisystem inflammatory syndrome in adults (MIS-A) following COVID-19 have been described. However, MIS-A in pregnancy is an extremely rare presentation that can cause a huge diagnostic dilemma to caregivers. We describe the successful management of a pregnant woman with MIS-A following SARS-CoV-2 infection.
. 2022 Jan 7;2022:4186846.
doi: 10.1155/2022/4186846. eCollection 2022.
An Unusual Presentation of COVID-19 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A) in a Pregnant Woman
Mohamed Rishard[SUP] 1 2 [/SUP], Suren Perera[SUP] 2 [/SUP], Kushan Jayasinghe[SUP] 2 [/SUP], Amila Rubasinghe[SUP] 2 [/SUP], Sanjaya Athapaththu[SUP] 2 [/SUP], Malindu Edirisinghe[SUP] 2 [/SUP], Prabhodana Ranaweera[SUP] 1 2 [/SUP], Tushani Ranawaka[SUP] 1 [/SUP], Athula Kaluarachchi[SUP] 1 2 [/SUP], Priyankara Jayawardana[SUP] 2 [/SUP], Zacky Haniffa[SUP] 2 [/SUP]
Affiliations
- PMID: 35013694
- PMCID: PMC8742152
- DOI: 10.1155/2022/4186846
Abstract
Based on available literature, pregnant women are at an increased risk of severe illness from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, compared to nonpregnant women. Consequences of coronavirus disease 2019 (COVID-19) in pregnancy have many implications in women's lives other than unfavorable obstetric outcomes. In addition to managing acute respiratory illness and symptoms, caregivers should be equipped to detect and manage the short-term, intermediate, and long-term consequences of SARS-CoV-2 infection as well. Many pregnant women can remain asymptomatic and continue their pregnancy without being diagnosed. Pregnancy outcomes and consequences of SARS-CoV-2 infected yet asymptomatic mothers have not been very well explained. Reports of a new multisystem inflammatory syndrome in children (MIS-C) and multisystem inflammatory syndrome in adults (MIS-A) following COVID-19 have been described. However, MIS-A in pregnancy is an extremely rare presentation that can cause a huge diagnostic dilemma to caregivers. We describe the successful management of a pregnant woman with MIS-A following SARS-CoV-2 infection.